Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-01-2001
Volume 2001 Supplement
Issue 2

Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.

External Link - article-5236.pdf

Articles in this issue
Creating a Successful Partnership with a Contract Manufacturer
Outsourcing Outlook
Creative Solutions in Client-CRO Relationships
Third-Party Technology Transfer
The Squeeze in Contract Manufacturing
Preparing Requests for Quotations for Commercial Pharmaceutical Manufacturing
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Stakes Rise for Blown Batches
Partnerships in Drug Discovery
Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Ascend Advanced Therapies Expands US Footprint in New Partnership

Susan Haigney
November 12th 2024
Article

Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

The Importance of Appropriate Supplier Oversight

Siegfried Schmitt
November 2nd 2024
Article

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, Technical, Parexel.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Arrow speed abstract blue background, communication data transfer technology concept. | Image Credit: ©Suppachok N

Tech Transfer in the New World of New Modalities

Susan Haigney
October 28th 2024
Article

Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

CMOs and Hybrid Companies Predicted to Hold 54% of Biologics Capacity in 2028, According to CPHI Annual Survey

Feliza Mirasol
October 8th 2024
Article

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.